Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
26.21-0.20 (-0.76%)
At close: 04:00PM EDT
25.11 -1.10 (-4.20%)
After hours: 04:19PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • J
    Went to Reviva Pharmaceuticals (RVPH). Their schizophrenia candiate proved much better than CERE' in Gold Standard clinical trials, much (much) better, and a wayyy smaller market cap. Obvious choice imo.
  • N
    RVPH blows away CERE. CERE is basically a joke compared to RVPH. Plenty of information on their board so I don't repeat it all here. RVPH has to go up about 95X just to reach CERE's valuation and about 175X to reach Karuna's valuation, but its phase 2 clinical trials were the most rigorous possible, it's impossible to make them more legitimate, so we can expect phase 3 trials now underway to reproduce the phase 3 trial's results. Buyout more likely than not, and either way should exceed CERE's and KRTX's market caps. Good luck!
  • D
    Are you guys still in CERE? They just got featured on the watchlist at (
  • R
    Got some $20 puts before close… whose laughing now ;)
  • R
    Last 4 days total volume is ~14 million, how can they complete the offering? Will they be filing new one with low price?
  • T
    Offerings next days
  • P
    That was a lot of volume EOD. We went from 800,000 to 1.6mil in 30min. They pushed it up 2%. I don’t know how this will end but I think MM’s are trying to crush 7/16 puts
  • D
    Big drop incoming. $18 by Friday.
  • R
    they need cash.. offering 99% certain
  • R
    How long it’s going to take to $20?
  • P
    Why are my puts down?
  • V
    Valentino Volpe
    Yahoo deleting my post after reading aloud the S-1 Preliminary Filings that show the company saying they don't plan to gerate revenue for years and have only inccured losses since inception.... 52 million for 2021 ended march 31st and 152.1 million net losses for ended december 31st 2020.
  • M
    Purely manipulated since the spike two weeks ago
  • T
    WHOOOOOSH --- the MOMOs are trying to escape quickly as the institutions are stepping in after-hours and ripping CERE back down to reality ..... now down $3.40 since the final 5 minutes of regular trading.
  • D
    Keep in mind just because they have a public offering at $25 doesn't mean it's worth $25 and or anyone will buy it at $25.
  • k
    $RVPH conversation
    Lets go $RVPH, $CERE, $SAVA, $ANVS. My top four investments in my portfolio for Schizophrenia and Alzheimer.
  • D
    Long way to Phase 2 and 3 clinical trials. They will need many more second offerings.
    Now 127 M outstanding shares plus 12 M new dilution. Still no pricing.
    May be there is no interest for pricey and speculative junior bio pharma.
  • R
    Offering 42 million shares ..